Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03691220 · ClinicalTrials.gov registry record · NA
Improving Medication Adherence in Adolescents Who Had a Liver Transplant
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT03691220 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 148 participants.
The verdict
NCT03691220, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The study's aim is to test a tailored telemetric intervention to reduce rejection incidence by improving medication adherence in a group of adolescent liver transplant recipients identified as nonadherent by a marker (the Medication Level Variability Index, MLVI).
Interventions
- BEHAVIORAL Telemetric Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2025-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03691220
The ClinicalTrials.gov registry entry for NCT03691220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telemetric Intervention is the first listed.
NCT03691220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03691220 about?
NCT03691220 is a clinical study titled "Improving Medication Adherence in Adolescents Who Had a Liver Transplant". The study's aim is to test a tailored telemetric intervention to reduce rejection incidence by improving medication adherence in a group of adolescent liver transplant recipients identified as nonadherent by a marker (the Medication Level Variability Index, MLVI).
What is the current status of trial NCT03691220?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2018-11-14. Estimated completion is 2025-10-22.
What interventions are being tested in trial NCT03691220?
The interventions under investigation include: Telemetric Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03691220?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.